Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

MapsPeople – Presentation of H1 2022 - 01.09.2022

By HC Andersen Capital
MapsPeople
MapsPeople announces its half-year report on Tuesday 30 August. The company’s CEO Michael Gram and Chairman Lars H. Brammer will present the results in a live event with a Q&A session on September 1st at 1:00 PM, where you can get an update on the recent business development, SaaS metrics, and insights about the current market conditions. In the latest Q1 2022 report, MapsPeople reached a total annual recurring revenue (ARR) of DKK 45.4 million at the end of the quarter, corresponding to a growth rate of 55% YoY. Growth was primarily driven by its MapsIndoors segment, and most of the growth came from partners. In Q1 2022, MapsPeople also accelerated its pipeline, tested automation tools, and developed the organization, including establishing its Singapore office. MapsPeople’s financial guidance for the full year 2022 was maintained, implying a total ARR in the range of DKK 75-85 million end of 2022. MapsPeople’s Q3 and Q4 are historically the strongest quarters with the highest growth rates. HC Andersen Capital receives payment from MapsPeople for a Corporate Visibility/Digital IR subscription agreement. /Kasper Lihn 10:11 AM 18:08-2022.

Recent videos

Life Science Companies as Investments | Life Science Night Dec. 9, 2025
16.12.2025 klo 09.30 Aiforia Technologies
Truecaller, Webcast, Press Conference, 2025
15.12.2025 klo 14.00 Truecaller
Herantis Pharma as an Investment | Life Science Night Dec 9, 2025
15.12.2025 klo 14.00 Herantis Pharma
Orion as an Investment | Life Science Night Dec. 9, 2025
13.12.2025 klo 13.50 Orion
A sit-down with CEO Remco Westermann
12.12.2025 klo 10.09 Verve Group
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.